In Alzheimer's, Parkinson's, and type 2 diabetes, harmful protein aggregates and deposits, known as amyloid plaques, develop.

No. 5 / 2025 Zealand Pharma appoints Utpal Singh as Chief Scientific Officer to drive next-generation peptide therapeutics ...

Leading the way with our groundbreaking research and innovative teaching spanning chemistry, physics and astronomy, and mathematics and statistics. Our students go on to make an impact across a huge ...

Olon S.p.A. is honored to announce its receipt of the esteemed 2025 CMO Excellence in Green Chemistry Award. This accolade, conferred by the ACS Green Chemistry Institute Pharmaceutical Roundtable ...

Decoy Therapeutics, Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide conjugate therapeutics, announces that Massachusetts Institute of ...

Northeastern University researchers resurrected an extinct plant gene, turning back the evolutionary clock to pave a path ...

Researchers have developed a pioneering, sustainable method for producing cadmium-based quantum dots (QDs) in water using a biocompatible chalcogen source. This fully aqueous, continuous flow process ...

Philipp Klahn, Senior Lecturer in Medicinal Chemistry and Chemical Biology Inspired by nature’s design, Philipp Klahn’s research focuses on the synthesis of bioactive molecules and drugs, with a ...

A new company has entered the drug discovery space with what it calls a “chemistry-first” platform. Colorado-based Cime Therapeutics has emerged from stealth with $2.1 million in preseed ...

To overcome these limitations, we engineered oncolytic viruses co-expressing neoantigens and neoantigen-binding major histocompatibility complex (MHC) molecules to force ectopic delivery of ...